Sign up here to receive the Virco newsletter with the latest updates on HIV resistance testing, clinical updates, published science and updates to Virco products & services.
As a research-based biotechnology company, Virco applies advanced technologies to improve the diagnosis and management of infectious diseases.
A pioneer in the field of HIV-1 drug resistance testing, we are dedicated to improve the quality of life for patients via diagnostics and health information technologies.
Clinical Update December 2009!
An analysis of the relative contributions of specific drugs to virological response.
© Virco BVBA 1995-2010. Last updated on: 12 January 2010. More info on Safe Harbor Privacy Policy
This site is intended for visitors from the United States and the European Union.
This site is intended for visitors from the United States and the European Union.